Lapaquistat acetate and current lipid-lowering treatment
01-05-TL-475-016
Phase 3 small_molecule terminated
Quick answer
Lapaquistat acetate and current lipid-lowering treatment for Hypercholesterolemia is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hypercholesterolemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated